Skip to content

Institutional care

Arega Institutional Care focuses its QHSE team on hospitals and care institutions for the commercialisation of three product lines:

Specialty solutions include closed-loop systems for preparation and administration of chemotherapy, monoclonal antibodies and antibiotics; Teva®’s portfolio of generic medicines, for which Arega has exclusive distributor rights; orphan drugs for the treatment of rare diseases.

Arega is the exclusive distributor of Teva® generic medicines.